Dexamethasone phosphate
-
Dexamethasone phosphate
structure -
-
CAS No:
312-93-6
-
Formula:
C22H30FO8P
-
Chemical Name:
Dexamethasone phosphate
-
Synonyms:
Pregna-1,4-diene-3,20-dione,9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-,(11β,16α)-;Pregna-1,4-diene-3,20-dione,9-fluoro-11β,17,21-trihydroxy-16α-methyl-,21-(dihydrogen phosphate);Pregna-1,4-diene-3,20-dione,9-fluoro-11β,17,21-trihydroxy-16α-methyl-,21-phosphate;(11β,16α)-9-Fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)pregna-1,4-diene-3,20-dione;Dexamethasone 21-phosphate;Betnelan phosphate;Dexamethasone phosphate;Dexamethasone 21-dihydrogen phosphate;Wymesone;Dexamethasone orthophosphate;Micromethason;2588541-25-5
-
Categories:
Active Pharmaceutical Ingredients > Hormones and the Endocrine System
-
CAS No:
Description
ChEBI: A steroid phosphate that is the 21-O-phospho derivative of dexamethasone.
Dexamethasone phosphate is a steroid phosphate that is the 21-O-phospho derivative of dexamethasone. It has a role as a glucocorticoid receptor agonist. It is a steroid phosphate, an 11beta-hydroxy steroid, a 17-hydroxy steroid, a 3-oxo-Delta(4) steroid, a fluorinated steroid and a tertiary alpha-hydroxy ketone. It derives from a dexamethasone. It is a conjugate acid of a dexamethasone phosphate(2-).
Dexamethasone phosphate Basic Attributes
472.4409642
472.44
206-232-0
2BP70L44PR
DTXSID2047430
2937290090
Characteristics
151.17000
2.01270
1.45g/cm3
669.6ºC at 760mmHg
358.7ºC
1.594
Oral-Mouse LD: >1000 mg/kg
Flammable; burning produces toxic phosphorus oxide and fluoride fumes
Safety Information
62
Xn
Ventilated, low temperature and dry
P201, P202, P260, P264, P270, P281, P308+P313, P314, P405, P501
H361
Drug Information
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
Decadron phosphate
Dexamethasone phosphate Use and Manufacturing
A pro-drug of Dexamethasone (D298800), an anti-inflammatory glucocorticoid. It was found that liposomal DXM-P inhibited both chronic inflammation and joint destruction, whereas free DXM-P failed to prevent joint destruction.
Human drugs -> Rare disease (orphan)|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Computed Properties
Molecular Weight:472.4
XLogP3:0.1
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:4
Exact Mass:472.16623307
Monoisotopic Mass:472.16623307
Topological Polar Surface Area:141
Heavy Atom Count:32
Complexity:973
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Dexamethasone phosphate
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
Decyl 3,5,5-trimethylhexyl hydrogen phosphate
85006-33-3
-
dexamethasone 21-(beta-isothiocyanatoethyl)thioether
131567-23-2
-
Dexamethasone β-D-glucuronide
152154-28-4
-
Benzenamine, phosphate (2:1) Formula
17843-02-6
-
Praseodymium phosphate (PrPO4) Formula
14298-31-8
-
Polyethylene glycol octyl ether acid phosphate Formula
31800-88-1
-
Benzeneethanamine, α-methyl-, phosphate (1:1) Structure
139-10-6
-
[[(2R,3S,4S,5R)-3,4-dihydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Structure
66097-68-5
-
What is Ethanol, 2-[2(or 4)-isododecylphenoxy]-, dihydrogen phosphate
100296-67-1
-
What is Ethanol, 2-[2(or 4)-isononylphenoxy]-, dihydrogen phosphate
100258-39-7